{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:30Z","timestamp":1791267150266,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Glaucoma is a multifactorial optic neuropathy that primarily affecting retinal ganglion cells (RGC). Brimonidine is an intraocular pressure-lowering drug with reported neuroprotective properties. This study aimed to compare the neuroprotective effects of topical and intraperitoneal (IP) brimonidine on RGCs from different retinal segments in a murine optic nerve crush (ONC) model. Methods: forty-one Balb\/c mice underwent unilateral ONC and were divided into three study groups: fifteen animals received saline drops twice per day and two additional IP injections of saline; fourteen mice received brimonidine drops twice per day; and 12 mice received brimonidine eye drops twice per day and two additional IP brimonidine injections. Animals were sacrificed seven days post-ONC, and immunohistochemical staining of retinal whole mounts was performed using neuronal NeuN and GFAP staining. Microscopic pictures of the central, middle, and peripheral regions of the retina were taken. The density of the retinal cells was assessed. Results: The total RGC density after ONC and RGC densities in all retinal eccentricities were significantly higher in the brimonidine eye drop and IP combination treatment group than in the saline drop + saline IP, and brimonidine drop treatment groups. Conclusions: brimonidine eye drops supplemented with IP brimonidine injections improved RGC survival in a preclinical model of ONC.<\/jats:p>","DOI":"10.1371\/journal.pone.0308671","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:40:45Z","timestamp":1723138845000},"page":"e0308671","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1658-7849","authenticated-orcid":true,"given":"Ruta","family":"Maciulaitiene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giedrius","family":"Kalesnykas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dainius Haroldas","family":"Pauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-7922","authenticated-orcid":true,"given":"Ingrida","family":"Januleviciene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"3","key":"pone.0308671.ref001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10384-020-00736-1","article-title":"What is glaucomatous optic neuropathy","volume":"64","author":"T Nakazawa","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"pone.0308671.ref002","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review. Vol. 311, JAMA","author":"RN Weinreb","year":"2014","journal-title":"American Medical Association"},{"key":"pone.0308671.ref003","doi-asserted-by":"crossref","first-page":"100953","DOI":"10.1016\/j.preteyeres.2021.100953","article-title":"Adaptive responses to neurodegenerative stress in glaucoma","volume":"84","author":"DJ Calkins","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"15","key":"pone.0308671.ref004","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.3390\/ijms22157994","article-title":"Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention","volume":"22","author":"S Vernazza","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0308671.ref005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","article-title":"Glaucoma: the retina and beyond. Vol. 132","author":"BM Davis","year":"2016","journal-title":"Acta Neuropathologica. Springer Verlag"},{"key":"pone.0308671.ref006","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jcjo.2016.07.013","article-title":"Glaucoma treatment trends: a review. Vol","volume":"52","author":"R Conlon","year":"2017","journal-title":"Canadian Journal of Ophthalmology. Elsevier B.V."},{"issue":"6","key":"pone.0308671.ref007","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3559","article-title":"Optic Nerve Crush in Mice to Study Retinal Ganglion Cell Survival and Regeneration","volume":"10","author":"EG Cameron","year":"2020","journal-title":"Bio Protoc"},{"issue":"7","key":"pone.0308671.ref008","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1167\/iovs.12-9712","article-title":"Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma","volume":"53","author":"G Kalesnykas","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 2","key":"pone.0308671.ref009","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1177\/112067210101102S03","article-title":"Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma","volume":"11","author":"LA Wheeler","year":"2001","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"pone.0308671.ref010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archopht.120.6.797","article-title":"Up-regulation of Brain-Derived Neurotrophic Factor Expression by Brimonidine in Rat Retinal Ganglion Cells","volume":"120","author":"H. Gao","year":"2002","journal-title":"Archives of Ophthalmology"},{"key":"pone.0308671.ref011","article-title":"From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Vol. 9","author":"LA Wheeler","year":"1999","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"pone.0308671.ref012","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1006\/exer.1994.1070","article-title":"Alpha-2 Adrenoceptor Mediated Changes in Aqueous Dynamics: Effect of Pertussis Toxin","volume":"58","author":"M Ogidigben","year":"1994","journal-title":"Exp Eye Res"},{"issue":"1","key":"pone.0308671.ref013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(99)00076-8","article-title":"Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients","volume":"128","author":"CB Toris","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"pone.0308671.ref014","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms21072262","article-title":"Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead","volume":"21","author":"R Boia","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0308671.ref015","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-6-4","article-title":"Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons","volume":"6","author":"WS Lambert","year":"2011","journal-title":"Mol Neurodegener"},{"issue":"6","key":"pone.0308671.ref016","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s10792-017-0768-z","article-title":"Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells","volume":"38","author":"D Marangoz","year":"2018","journal-title":"Int Ophthalmol"},{"key":"pone.0308671.ref017","article-title":"Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage","author":"F Conti","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"pone.0308671.ref018","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/ALN.0b013e318286cf36","article-title":"Neuroprotective Effects of Dexmedetomidine against Glutamate Agonist-induced Neuronal Cell Death Are Related to Increased Astrocyte Brain-derived Neurotrophic Factor Expression","volume":"118","author":"V Degos","year":"2013","journal-title":"Anesthesiology"},{"key":"pone.0308671.ref019","first-page":"246","article-title":"Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells","volume":"16","author":"KYC Lee","year":"2010","journal-title":"Mol Vis"},{"key":"pone.0308671.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8397521","article-title":"Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications","volume":"2019","author":"L Fu","year":"2019","journal-title":"Biomed Res Int"},{"issue":"10","key":"pone.0308671.ref021","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1167\/iovs.08-2078","article-title":"\u03b12 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity","volume":"49","author":"CJ Dong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"pone.0308671.ref022","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.397","article-title":"Non-amyloidogenic effects of \u03b12 adrenergic agonists: Implications for brimonidine-mediated neuroprotection","volume":"7","author":"S Nizari","year":"2016","journal-title":"Cell Death Dis"},{"issue":"9","key":"pone.0308671.ref023","first-page":"2074","article-title":"Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death","volume":"42","author":"MP Lafuente","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0308671.ref024","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/S0039-6257(01)00205-3","article-title":"Retinal Ganglion Cell Death Induced by Retinal Ischemia","volume":"45","author":"M Vidal-Sanz","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"pone.0308671.ref025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0952523802191152","article-title":"Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat","volume":"19","author":"RK Lai","year":"2002","journal-title":"Vis Neurosci"},{"issue":"9","key":"pone.0308671.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161862","article-title":"Neuroprotection by \u03b12-adrenergic receptor stimulation after excitotoxic retinal injury: A study of the totalpopulation of retinal ganglion cells and their distribution in the chicken retina","volume":"11","author":"C Galindo-Romero","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"pone.0308671.ref027","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic hypertension","volume":"42","author":"E WoldeMussie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"pone.0308671.ref028","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2008.02.008","article-title":"Retinal ganglion ocular cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments","volume":"86","author":"M Hern\u00e1ndez","year":"2008","journal-title":"Exp Eye Res"},{"issue":"1","key":"pone.0308671.ref029","first-page":"65","article-title":"Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration","volume":"40","author":"E Yoles","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0308671.ref030","doi-asserted-by":"crossref","DOI":"10.1001\/archophthalmol.2009.9","article-title":"Experimental and Clinical Evidence for Brimonidine as an Optic Nerve and Retinal Neuroprotective Agent An Evidence-Based Review. Vol","volume":"127","author":"M Saylor","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"pone.0308671.ref031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: Results from the low-pressure glaucoma treatment study","volume":"151","author":"T Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"pone.0308671.ref032","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00417-005-1160-7","article-title":"Topical brimonidine reduces collateral damage caused by laser photocoagulation for choroidal neovascularization","volume":"243","author":"JR Ferencz","year":"2005","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"},{"issue":"1","key":"pone.0308671.ref033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/jop.2007.0022","article-title":"A pilot study of topical treatment with an \u03b12-agonist in patients with retinal dystrophies","volume":"24","author":"S Merin","year":"2008","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"12","key":"pone.0308671.ref034","first-page":"724","article-title":"The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus","volume":"102","author":"LK Mondal","year":"2004","journal-title":"J Indian Med Assoc"},{"issue":"5","key":"pone.0308671.ref035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00417-005-0102-8","article-title":"Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): A 3-month, double-masked, randomised, placebo-controlled trial","volume":"244","author":"B Wilhelm","year":"2006","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"},{"issue":"7","key":"pone.0308671.ref036","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.oret.2023.03.001","article-title":"Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration","volume":"7","author":"WR Freeman","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"pone.0308671.ref037","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajo.2008.08.005","article-title":"Effect of Brimonidine on Retinal Ganglion Cell Survival in an Optic Nerve Crush Model","volume":"147","author":"K Ma","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"pone.0308671.ref038","article-title":"Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia","volume":"21","author":"C Bin","year":"2021","journal-title":"BMC Anesthesiol"},{"issue":"2","key":"pone.0308671.ref039","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/exer.2001.1122","article-title":"Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: A dose response in vivo study","volume":"74","author":"MP Lafuente","year":"2002","journal-title":"Exp Eye Res"},{"key":"pone.0308671.ref040","article-title":"Topical brimonidine or intravitreal bdnf, cntf, or bfgf protect cones against phototoxicity","author":"FJ Valiente-Soriano","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"pone.0308671.ref041","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.exer.2006.01.025","article-title":"Three experimental glaucoma models in rats: Comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death","volume":"83","author":"JH Urcola","year":"2006","journal-title":"Exp Eye Res"},{"key":"pone.0308671.ref042","doi-asserted-by":"crossref","unstructured":"Ahmed FAKM, Chaudhary P, Sharma SC. Effects of increased intraocular pressure on rat retinal ganglion cells [Internet]. Vol. 19, Int. J. Devl Neuroscience. 2001. Available from: www.elsevier.nl\/locate\/ijdevneu","DOI":"10.1016\/S0736-5748(00)00073-3"},{"key":"pone.0308671.ref043","article-title":"Experimental glaucoma in the primate induced by latex microspheres [Internet]. Vol. 111","author":"AJ Weber","year":"2001","journal-title":"Journal of Neuroscience Methods"},{"key":"pone.0308671.ref044","article-title":"The Interaction Between Microglia and Macroglia in Glaucoma. Vol. 15, Frontiers in Neuroscience","author":"X Zhao","year":"2021","journal-title":"Frontiers Media S.A."},{"key":"pone.0308671.ref045","first-page":"1","article-title":"Glia-neuron interactions in the mammalian retina. Vol. 51, Progress in Retinal and Eye Research","author":"E Vecino","year":"2016","journal-title":"Elsevier Ltd"},{"issue":"3","key":"pone.0308671.ref046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018305","article-title":"Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells","volume":"6","author":"BS Ganesh","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"pone.0308671.ref047","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","article-title":"The tripartite synapse: roles for gliotransmission in health and disease","volume":"13","author":"MM Halassa","year":"2007","journal-title":"Trends Mol Med"},{"key":"pone.0308671.ref048","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2009.06.031","article-title":"Tripartite synapses: Roles for astrocytic purines in the control of synaptic physiology and behavior","volume":"57","author":"MM Halassa","year":"2009","journal-title":"Neuropharmacology"},{"key":"pone.0308671.ref049","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1073858403253460","article-title":"Glaucomatous Optic Neuropathy: When Glia Misbehave. Vol. 9","author":"AH Neufeld","year":"2003","journal-title":"Neuroscientist"},{"issue":"8","key":"pone.0308671.ref050","first-page":"2268","article-title":"Effect of Brimonidine on Rabbit Trabecular Meshwork Hyaluronidase Activity","volume":"41","author":"J Benozzi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0308671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:41:23Z","timestamp":1723138883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0308671"}},"subtitle":[],"editor":[{"given":"Sanjoy","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0308671","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}